2,2',3,3',4,4',5,5',6-NONACHLOROBIPHENYL(40186-72-9)
- Name: 2,2',3,3',4,4',5,5',6-NONACHLOROBIPHENYL
- Synonyms:2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl;2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl;2,3,4,5,6,2',3',4',5'-Nonachlorobiphenyl;Biphenyl, 2,2',3,3',4,4',5,5',6-nonachloro-;PCB NO 206;
- Molecular Formula:C12HCl9
- Molecular Weight:464.217
- CAS Registry Number:40186-72-9
- EINECS:
- Melting Point:
- Water Solubility:-10.26
Other Product
- 85983-19-3/2-[4-(3-chlorophenoxy)phenoxy]ethyl ethylcarbamate
- 750596-66-8/Protein (synthetic human plasma kallikrein-inhibiting)
- 83540-33-4/2,4-Pyrimidinediamine, 6,6-(1,4-piperazinediyl)bis-, 3,3-dioxide
- 5896-59-3/Convolvamine hydrochloride
- 2000-40-0/Trichloro-ethylol-urea
- 36174-42-2/1,2,5-trimethyl-4-phenyl-5-(piperidin-1-ylmethyl)piperidin-4-yl (2E)-3-phenylprop-2-enoate dihydrochloride
- 171091-06-8/Benzene, ethenyl-, ar-bromo derivs., polymers with propene, graft
- 155709-24-3/AC-LEU-ARG-HIS-TYR-LEU-ASN-LEU-LEU-THR-ARG-GLN-ARG-TYR-NH2
- 39516-27-3/1,10-Dodecanediol
- 163634-08-0/Benzenepropanol,4-hydroxy-b-[(1E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-3-methoxy-,(bS)-
- 10158-64-2/Xylaric acid
- 39388-60-8/(1R,2R,3R,4'aα,7'β,9'aβ)-3-Acetoxymethylhexahydro-3-methyl-8'-methylene-1',9'-dioxospiro[cyclohexane-1,4'(3'H)-[1H-7,9a]methanocyclohepta[c]pyran]-2-carbaldehyde
- 52474-59-6/[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl]methyl hydrogen phosphate (non-preferred name)
- 40186-72-9/2,2',3,3',4,4',5,5',6-NONACHLOROBIPHENYL
- 158675-46-8/1H-Benzimidazole-6-sulfonicacid, 2-[(methoxycarbonyl)amino]-, 2-[(5-nitro-2-furanyl)methylene]hydrazide
- 16855-16-6/2-fluoro-alpha-methyltyrosine
- 109184-80-7/2-({[2-hydroxy-3-(2-methylphenoxy)propoxy]carbonyl}amino)ethanaminium chloride
- 72141-54-9/N,N-dimethyl-4-[(4-{[7-(trifluoromethyl)quinolin-4-yl]amino}phenyl)carbonyl]piperazine-1-sulfonamide
- 22016-03-1/3'-hydroxyacetoacetanilide
- 190962-45-9/Kinabalurine E
- 157175-98-9/See R-D-Glucopyranoside,methyl,monoether with triglycerol,dioctadecanoate
- 131653-22-0/b-D-Glucopyranoside,(S)-(4-hydroxy-3-methoxyphenyl)[(3S,4R,5S)-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-4-(hydroxymethyl)-3-furanyl]methyl(9CI)
- 155277-54-6/Spiro[2a,6a-epoxynaphth[2,3-b]oxirene-2(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3(6H)-one,6,7-bis(acetyloxy)-7,7a-dihydro-, (1aR,2aR,6S,6aS,7S,7aR)-rel- (9CI)
- 149496-33-3/2H-1,7-Dioxacyclopent[cd]indene-2,6-diol,5-[(3E)-4,8-dimethyl-3,7-nonadienyl]octahydro-, (2aS,4aS,5R,7aR,7bR)- (9CI)
- 19611-04-2/dehydro-
- 93966-54-2/(2,6,10,17,21,25-Hexahydroxy-4,4,8,8,19,19,23,23,23-octamethyl-12,15-diaza-4,8,19,23-tetraazoniahexacosane-1,26-diyl)bis(tris(2-hydroxyethyl)ammonium) hexachloride dihydrochloride
- 32366-79-3/N-(guanin-8-yl)-2-aminofluorene
- 97889-88-8/Sorbitan, ditetradecanoate
- 15419-94-0/2-Hydroxy-4-acryloyloxybenzophenone
- 6397-32-6/(methoxymethyl)(dimethyl)phosphane oxide
